No Detail Found!

Effectiveness of traditional Chinese medicine transdermal therapy in preventing lower limb deep vein thrombosis in chronic glomerulonephritis and uremic patients

Author(s)
Wei Yong Shengzhou People's Hospital (First Affiliated Hospital of Zhejiang University School of Medicine Shengzhou Branch),,China
Abstract
The aim of this study was to assess the impact of traditional Chinese medicine-based transdermal treatment for the prevention of deep vein thrombosis of the lower limbs in patients with chronic glomerulonephritis and uremia. 100 patients hospitalized from January 2022 to July 2024 were randomly divided into a control group (n=50), which was given routine treatment and a study group (n=50), which was given TCM transdermal treatment in addition to herbal formulations at certain acupoints. The treatment was conducted for a period of one month. Clinical endpoints evaluated were the occurrence of deep venous thrombosis (DVT), lower limb pain, Homans sign, femoral triangle tenderness, limb circumference, femoral venous blood flow and coagulation function in terms of prothrombin time (PT), activated partial thromboplastin time (APTT), platelet count (PLT), fibrinogen (FIB) and D-dimer (D-D). The study group presented with significantly lower incidence of DVT, improved venous blood flow and reduced limb swelling and pain compared to the control group (P<0.05). PT and APTT were significantly longer and PLT, FIB and D-D levels were decreased (P<0.05). No severe adverse events were observed and treatment compliance was improved in the study group. These findings suggest that TCM-guided transdermal therapy is a safe and effective adjunctive method for reducing DVT risk in CGN uremia patients.
Publication Details
Page(s) 1859-1866
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Thrombosis, Traditional Chinese medicine, transdermal therapy
References
Abdalhabib EK,Jackson DE,Alzahrani B,Elfaki E,Hamza A,Alanazi F,Ali EI,Algarni A,Ibrahim IK .2022 .Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins. Blood Coagul. Fibrinolysis, 33(3) : 149-152.
Al-Worafi YM .2024 .Glomerulonephritis management in developing countries. In handbook of medical and health sciences in developing countries: Education, practice and research, : 1-24.
Bhatt M,Braun C,Patel P,Patel P,Begum H,Wiercioch W,Varghese J,Wooldridge D,Alturkmani HJ,Thomas M,Baig M M .2020 .Diagnosis of deep vein thrombosis of the lower extremity: A systematic review and meta-analysis of test accuracy. Blood Adv., 4(7) : 1250-1264.
Cai N,Han Y,Wang G,Huang X,Bo X,Qin H X .2024 .Effectiveness of Taohong Siwu decoction in the prevention of deep vein thrombosis in hip surgery patients: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 103(9) : e37241.
Cheng J,Fu Z,Zhu J,Zhou L,Song W .2020 .The predictive value of plasminogen activator inhibitor-1, fibrinogen and D-dimer for deep venous thrombosis following surgery for traumatic lower limb fracture. Ann. Palliat. Med, 9(5) : 3385-3392.
Cheung CY,Parikh J,Farrell A,Lefebvre M,SummaSorgini C and Battistella M M .2021 .Direct oral anticoagulant use in chronic kidney disease and dialysis patients with venous thromboembolism: A systematic review of thrombosis and bleeding outcomes. , 55(6) : 711-722.
Ding M,Zhang Q,Zhang M,Jiang X,Wang M,Ni L,Gong W,Huang B,Chen J .2022 .Phosphate overload stimulates inflammatory reaction via PiT-1 and induces vascular calcification in uremia. J. Ren. Nutr, 32(2) : 178-188.
Ellenbogen MI,Ardeshirrouhanifard S,Segal JB,Streiff MB,Deitelzweig SB,Brotman DJ SB .2022 .Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end-stage kidney disease: A national cohort study. J. Hosp. Med, 17(10) : 809-818.
Erben Y,Marquez CP,Prudencio M,Fortich S,Gendron T,Sanghavi D,Hickson L,Li Y,Edwards MA,Ritchie C,Franco PM C .2023 .Race affects adverse outcomes of deep vein thrombosis, pulmonary embolism and acute kidney injury in coronavirus disease 2019 hospitalized patients. J. Vasc. Surg, 11(1) : 19-24.
Goraya N and Wesson DE .2020 .Novel dietary and pharmacologic approaches for acid-base modulation to preserve kidney function and manage uremia. Curr. Opin. Nephrol, 29(1) : 39-48.
Guo PC,Li N,Zhong HM,Zhao GF .2022 .Clinical effectiveness of a pneumatic compression device combined with low-molecular-weight heparin for the prevention of deep vein thrombosis in trauma patients: A single-center retrospective cohort study. World J. Emerg. Med, 13(3) : 189-195.
Huang G,Han F,Wu H,Fan T,Guo W .2024 .Risk factors of lower extremity deep vein thrombosis after artificial femoral head replacement for elderly femoral neck fractures and a nomogram model construction. Altern. Ther. Health Med, 30(8) : 325-331.
Huang H,Pan J,Han Y,Zeng L,Liang G,Yang W,Liu J .2021 .Chinese herbal medicines for promoting blood circulation and removing blood stasis for preventing deep venous thrombosis after total hip arthroplasty: A systematic review and meta-analysis. Comb. Chem. High Throughput. Screen, 24(7) : 893-907.
Idasiak-Piechocka I,Miedziaszczyk M,Woźniak A,Pawliczak E,Kaczmarek E,Oko A .2023 .Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis. Am. J. Physiol. Cell Physiol, 325(5) : 1267-1275.
Jawale CV,Li DD,Ramani K,Lin L,Li K,Methe B,Biswas PS B .2021 .Uremia coupled with mucosal damage predisposes mice with kidney disease to systemic infection by commensal Candida albicans. Immunohorizons, 5(1) : 16-24.
Keller Jr RW,Kopple JD,Kalantar-Zadeh K .2020 .Perspiration interventions for conservative management of kidney disease and uremia. Curr. Opin. Nephrol, 29(1) : 57-63.
Kiewisz J,Pawłowska A,Winiarska A,PerkowskaPtasińska A,Skowrońska A,Godlewski J,Kmieć Z,Stompór T .2022 .Serum WNT4 protein as an indicator of chronic glomerulonephritis but not a marker of inflammatory cell infiltration and fibrosis: A preliminary study. Adv. Clin. Exp. Med, 31(3) : 249-259.
Yan LI,Jing-Ping GE,Ke MA,Yuan-Yuan YI,Juan HE,Jian-Ping GU .2022 .The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways. Chin. J. Nat. Med, 20(9) : 679-690.
Li Z,Yan M,Wang Z,An Y,Wei X,Li T,Xu M,Xia Y,Wang L,Gao C .2023 .Ferroptosis of endothelial cells triggered by erythrophagocytosis contributes to thrombogenesis in uremia. , 123(12) : 1116-1128.
Liu Y,Li Y,Wang X,Huang Y,Zhang Q,Shi K,Ran C,Hou J,Wang X .2020 .Fufang Banmao capsule, a traditional Chinese medicinal formulation, enhances the survival of patients with hepatocellular carcinoma and Vp3-4 portal vein tumor thrombosis undergoing supportive treatment. J. Altern. Complement Med, 26(10) : 956-965.
Lu K,Liao QQ,Zhu KW,Yao Y,Cui XJ,Chen P,Bi Y,Zhong M,Zhang H,Tang JC,Yu Q .2024 .Efficacy and safety of different doses of rivaroxaban and risk factors for bleeding in elderly patients with venous thromboembolism: A real-world, multicenter, observational, cohort study. Adv. Ther., 41(1) : 391-412.
Luo XL,Liang J,Gao DK,Fang CR,Chen YT,Na Q,Liu JJ .2023 .Network pharmacological and molecular docking verification of the mechanism of Osteoking in preventing deep vein thrombosis of lower limb. Eur. Rev. Med, 27(21) : 10255-10263.
Ma X,Xu Y,Qian J,Dai B .2022 .Analysis of influencing factors of community-acquired pneumonia with deep venous thrombosis in elderly communities. Ann. Palliat. Med, 11(6) : 1997-2006.
Marshall AC .2020 .Traditional Chinese medicine and clinical pharmacology. In drug discovery and evaluation: Methods in clinical pharmacology. , : 455-482.
Qazi SA,Qazi RA,Ahmed T,Rehman L,Javeed F,Aziz HF .2023 .The diagnostic accuracy of straight leg raise test in patients more than 60 years of age suffering lumbar disk herniation with low back pain and sciatica. J. Neurosci. Rural. Pract, 14(4) : 610-614.
Rudnin S,Kaminsky J,Ghosh R,Webb R,Fu W,Tama M,Hayim M,Hahn B,Greenstein J .2022 .Distribution of lower extremity deep vein thrombosis and implications for limited compression ultrasound examinations. J. Emerg. Med, 63(3) : 348-354.
Salem KM,Saadeddin Z,Go C,Malak OA,Eslami MH,Hager E,Al-Khoury G,Chaer RA,Avgerinos ED .2021 .Risk factors for acute kidney injury after pharmacomechanical thrombolysis for acute deep vein thrombosis. J. Vasc. Surg, 9(4) : 868-873.
Kalantar-Zadeh Tantisattamo E,K Tantisattamo E .2021 .Editorial: Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: Past, present and future. Curr. Opin. Nephrol. Hypertens, 30(1) : 1-4.
Uematsu H,Shinoda K,Saito A,Sakai K A .2023 .Deep venous thrombosis in a kidney transplant recipient with COVID-19: A case report. CEN. Case Rep, 12(1) : 98-103.
Wang L,Xu ZJ,Zhang L ZJ .2024 .A comparison between fondaparinux sodium and low-molecularweight heparin in preventing patients undergoing hip replacement from deep vein thrombosis. J. Musculoskelet Neuronal Interact., 24(2) : 185-191.
Wortmann JK,Barco S,Fumagalli RM,Voci D,Hügel U,Cola R,Spirk D,Kucher N,Sebastian T .2023 .Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis. , 52(6) : 416-422.
Zheng D,Qi G,Adu IK,Wu H,Zhu M H .2022 .Efficacy of traditional Chinese medicine combined with rivaroxaban in the treatment of lower extremity deep vein thrombosis: A meta-analysis. Medicine (Baltimore), 101(39) : e29483.
0

Citations

0

Downloads

96

Views